HUMAN PAPILLOMA VIRUS (HPV)
Clinical trials for HUMAN PAPILLOMA VIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wart treatment showdown: which injection wins?
Disease control CompletedThis study tested two different injected treatments for skin warts caused by HPV. 64 adults received either a furosemide-digoxin combination or polidocanol. Researchers checked how well each cleared the warts and tracked side effects and return of warts over 6 months.
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE2 • Sponsor: Benha University • Aim: Disease control
Last updated May 17, 2026 03:26 UTC
-
Wart war: new combo therapy shows promise in clinical trial
Disease control CompletedThis study tested three ways to treat warts caused by HPV: a topical cream (salicylic acid/lactic acid), an injection of candida antigen, and a combination of both. 126 people aged 5 to 60 with warts took part. The goal was to see which treatment works best at making warts disapp…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE2 • Sponsor: Benha University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC